GRK5 and Alzheimer disease: Reduced levels of membrane (functional) GRK5 increased soluble β-amyloid in vitro, and decreased GRK5 membrane localization occurs in vivo as well as in an AD transgenic model and postmortem human AD brain samples [6, 7].